⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 19, 2014HaematologicaOpen Access

Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia

Manja Meggendorfer T. Haferlach Tamara Alpermann Sabine Jeromin C. Haferlach Wolfgang Kern Susanne Schnittger

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) are rare entities grouped into the World Health Organisation (WHO) categories myeloproliferative and myelodysplastic/myeloproliferative neoplasms (MPN and MDS/MPN overlap), respectively.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Meggendorfer et al. (2014) studied this question.

synapsesocial.com/papers/6a83878d6914367a60951256 https://doi.org/10.3324/haematol.2014.113159

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Platelet and megakaryocyte function in the pathogenesis of POEMS syndromeHaematologica · 2026
2Salvage-free, transplantation-free survival: a proposal for a new clinical endpoint in acute myeloid leukemiaHaematologica · 2026
3Adeno-associated virus gene therapy for hemophilia B: a comparative appraisal of the licensed productsHaematologica · 2026
4CD34+-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a large cohort study focusing on haploidentical transplantationHaematologica · 2026
5Distinct clinical and molecular profiles of acute myeloid leukemia defined by mutations in IDH1, IDH2, and TET2Haematologica · 2026
6Depletion of CD19-positive B-cells and dexamethasone premedication may result in immune suppression in patients with B-precursor acute lymphoblastic leukemia after consolidation treatment with blinatumomabHaematologica · 2026
7Prospective study of longitudinal geriatric assessment with risk-adapted interventions for older patients in allogeneic hematopoietic cell transplantationHaematologica · 2026
8The importance of preparation for or achieving accreditation for small and high volume hematopoietic cell transplantation programsHaematologica · 2026
9BCL6 in B-cell lymphomas: old target, new tricks?Haematologica · 2026
10Platelet transfusion biology: from hemostatic support to inflammatory and immune signalingHaematologica · 2026

More from Haematologica

More from Munich Leukemia Laboratory (Germany)